.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 022334

« Back to Dashboard
NDA 022334 describes AFINITOR, which is a drug marketed by Novartis and Novartis Pharm and is included in two NDAs. It is available from one supplier. There are nine patents protecting this drug and two Paragraph IV challenges. Additional details are available on the AFINITOR profile page.

The generic ingredient in AFINITOR is everolimus. There are nine drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the everolimus profile page.

Summary for NDA: 022334

Tradename:
AFINITOR
Applicant:
Novartis
Ingredient:
everolimus
Patents:8
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 022334

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
AFINITOR
everolimus
TABLET;ORAL 022334 NDA Novartis Pharmaceuticals Corporation 0078-0566 0078-0566-51 28 BLISTER PACK in 1 CARTON (0078-0566-51) > 1 TABLET in 1 BLISTER PACK (0078-0566-61)
AFINITOR
everolimus
TABLET;ORAL 022334 NDA Novartis Pharmaceuticals Corporation 0078-0567 0078-0567-51 28 BLISTER PACK in 1 CARTON (0078-0567-51) > 1 TABLET in 1 BLISTER PACK (0078-0567-61)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength5MG
Approval Date:Mar 30, 2009TE:RLD:No
Patent:5,665,772*PEDPatent Expiration:Mar 9, 2020Product Flag?Substance Flag?Delist Request?Y
Patent:6,004,973*PEDPatent Expiration:Jan 12, 2017Product Flag?Substance Flag?Delist Request?Y
Patent:7,297,703*PEDPatent Expiration:Jun 6, 2020Product Flag?Substance Flag?Delist Request?Y


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc